Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
99.32
+1.15 (1.17%)
At close: Oct 31, 2025, 4:00 PM EDT
99.32
0.00 (0.00%)
After-hours: Oct 31, 2025, 4:31 PM EDT
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $7.22 billion as of October 31, 2025. Its market cap has decreased by -0.06% in one year.
Market Cap
7.22B
Enterprise Value
6.22B
1-Year Change
-0.06%
Ranking
Category
Stock Price
$99.32
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $7.22B, an increase of 807.23%. That is a compound annual growth rate of 67.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 7.08B | 27.27% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
| Jul 29, 2021 | 795.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 236.67B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |